Entities / Company
Inovio Pharmaceuticals.
American biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 36
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Inovio Pharmaceuticals received reports on company developments and is being tracked by financial blogs Benzinga and MarketBeat.Some support3 reports
-
Inovio Pharmaceuticals and Pyxis Oncology are both small-cap healthcare companies.Some support1 report
-
Inovio Pharmaceuticals and Synlogic, Inc. are identified as competing small-cap healthcare companies.Some support2 reports
One to three months ago
Gone quiet
No new reports in 90+ days-
Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.Speculative2 reports
-
Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.Speculative1 report
-
FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Inovio Pharmaceuticals this week
News at the entities that move Inovio Pharmaceuticals most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Inovio Pharmaceuticals
-
Jefferies Financial Group Mentioned togetherGE Vernova received a 'buy' rating and target price raise from Jefferies, alongside required SEC filings on May 27, 2026.Moves Inovio Pharmaceuticals
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves Inovio Pharmaceuticals
-
Ernst & Young LLP StructuralCRISPR Therapeutics announced that A.J. Silver will succeed Raju Prasad as CFO, following Silver's time at Ernst & Young LLP.Moves Inovio Pharmaceuticals
-
MarketBeat Mentioned togetherTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves Inovio Pharmaceuticals
-
Benzinga Mentioned togetherBenzinga generated content regarding the financial performance of Gilead Sciences on June 17, 2026.Moves Inovio Pharmaceuticals
Connections
The 6 strongest of 36, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Inovio Pharmaceuticals relies on the FDA for regulatory approval and designation of its pharmaceutical products.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides investment ratings and price targets for Inovio Pharmaceuticals.
-
Securities and Exchange Commission Structural
Inovio Pharmaceuticals is formally regulated by the Securities and Exchange Commission.
-
Ernst & Young LLP Structural
Shareholders approved Ernst & Young LLP to serve as the independent registered public accounting firm for Inovio Pharmaceuticals.
-
MarketBeat Mentioned together
MarketBeat tracks Inovio Pharmaceuticals as part of general financial blog coverage.
-
Benzinga Mentioned together
Benzinga functions as a financial news service that covers and reports on company developments regarding Inovio Pharmaceuticals.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsAugust 2026
1 eventShow 1 earlier month
June 2026
3 events- Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.
- Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.